Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 332
Immune Disorders Drugs 209
Biopharmaceuticals 178
Musculoskeletal Disorders Drugs 126
Genomics 114
Cardiovascular Drugs 106
Biotechnology 83
Pharmaceuticals 81
Drug Discovery 78
Endocrine and Metabolic Disorders Drugs 77
Biosimilars and Biosuperiors 72
Allergy and Immunology 67
Infusions and Injectables 63
Leukemia Drugs 62
Hematological Drugs 60
Oncology 52
Clinical Trials 51
Dermatological Drugs 50
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 45
Women's Health 44
Needles and Syringes 40
Drug Delivery 38
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 29
Brain Cancer Drugs 28
Proteomics 27
Enzymes 27
Gastrointestinal Drugs 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Analgesics 24
Immunosuppressive Drugs 24
Infectious Diseases Drugs 23
Lymphoma Drugs 22
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Dermatology 18
Optical 17
Therapeutic Area 16
Healthcare Services 15
Respiratory Drugs 15
Urology and Nephrology 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Gastroenterology 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Biomarkers 7
Anti-Obesity Drugs 7
Neurology 6
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Animal Pharmaceuticals 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Company Reports 4
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

2,085 Results (Page 47 of 105)
- Relevance
  Sort by

Glioma - Market Insight, Epidemiology, and Market Forecast - 2036

 Report
July 2026
394 Pages
Global

From

€7345EUR$7,990USD£6,260GBP

Brain Tumor Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Chylomicronemia Syndrome Market - Global Forecast 2026-2032

 Report
September 2026
196 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Glioma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
181 Pages
Global

From

€4137EUR$4,500USD£3,526GBP

Morquio Syndrome Drugs Market - Global Strategic Business Report

 Report
October 2026
467 Pages
Global

From

€5378EUR$5,850USD£4,583GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Dercum's Disease Market - Global Strategic Business Report

 Report
October 2026
383 Pages
Global

From

€5378EUR$5,850USD£4,583GBP

Drug & Gene Delivery System Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

 Report
July 2023
124 Pages
Global

From

€3500EUR$4,079USD£3,087GBP

Colorectal Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
550 Pages
Global

From

€4596EUR$5,000USD£3,917GBP

Bispecific Antibodies Market Size, Share & Industry Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune Disorder and Others), By Regional Outlook and Forecast, 2023 - 2030

 Report
June 2023
126 Pages
Global

From

€3309EUR$3,600USD£2,820GBP

Hidradenitis Suppurativa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
February 2022
106 Pages
Global

From

€1838EUR$2,000USD£1,567GBP

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

 Report
August 2018
340 Pages
Global

From

€3216EUR$3,499USD£2,741GBP

Biologics Market Report 2025-2035

 Report
March 2025
367 Pages
Global

From

€5282EUR$5,948USD£4,350GBP

Cutaneous T-Cell-Lymphoma Market - Global Forecast 2026-2032

 Report
January 2026
195 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Kidney Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
May 2022
155 Pages
Global

From

€1838EUR$2,000USD£1,567GBP

Regenerative Medicine Collaboration and Licensing Deals 2019-2026

 Report
May 2026
800 Pages
Global

From

€4592EUR$4,995USD£3,913GBP

Viral Gastroenteritis Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Nanomedicine Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

T-Xell Lymphoma - Global Strategic Business Report

 Report
October 2026
281 Pages
Global

From

€5378EUR$5,850USD£4,583GBP

BCL-2 b-Cell Lymphoma 2 Inhibitors Market - Global Strategic Business Report

 Report
October 2026
204 Pages
Global

From

€5378EUR$5,850USD£4,583GBP

Hairy Cell Leukemia - Global Strategic Business Report

 Report
October 2026
273 Pages
Global

From

€5378EUR$5,850USD£4,583GBP

2,085 Results (Page 47 of 105)
- 1
- 45
- 46
- 47
- 48
- 49

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.